Join Growin Stock Community!

Regentis biomaterials ltd.RGNT.US Overview

US StockHealthcare
(No presentation for RGNT)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

RGNT AI Insights

RGNT Overall Performance

RGNT AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

RGNT Recent Performance

-8.37%

Regentis biomaterials ltd.

0.05%

Avg of Sector

-0.31%

S&P500

RGNT PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

RGNT Key Information

RGNT Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

RGNT Profile

Price of RGNT

RGNT FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

RGNT Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1

No related data records

  • How much cash does RGNT have?

    At the end of the period, Regentis biomaterials ltd. (RGNT) held Total Cash and Cash Equivalents of 5.02M, accounting for 0.12 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.